Strata Oncology, Inc. — Form D
Strata Oncology, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-22. The offering totals $10.0M, of which $6.1M was reported sold. Industry: Other.
Offering
- Filed: 2024-11-22
- Form: D
- Accession: 0001668497-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $6.1M
- Remaining: $3.9M
- Investors: 14
- Date of first sale: 2024-11-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-530232
Issuer
- Name: Strata Oncology, Inc.
- CIK: 0001668497
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 8170 JACKSON RD., ANN ARBOR, MI, 48103
- Phone: 7349040365
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Keith Flaherty | Director | Boston, MA |
| Jan Garfinkle | Director | Maple Grove, MN |
| Christopher O'Donnell | Director | Kingston, RI |
| James Pavlik | Director | Chicago, IL |
| Daniel Rhodes | Director | Ann Arbor, MI |
| David Rubin | Director | Ann Arbor, MI |
| Jeffrey Williams | Director | Lakewood, CO |
| Matthew Martin | Executive Officer | Ann Arbor, MI |
| Daniel Rhodes | Executive Officer | Ann Arbor, MI |
| Jeffrey Williams | Executive Officer | Lakewood, CO |
| Prem Tumkosit | Director | Santa Cruz, CA |
| William Burkoth | Director | Ann Arbor, MI |
| Nicole Walker | Director | Ann Arbor, MI |
Other filings by this issuer (3)
More